IndiaTickerAnnual Report 2026 - Bliss GVS Pharma LimitedBSE · annual report · 214 pages
VerifiedArchived copy Company dossier
Bliss GVS Pharma
NSE:BLISSGVS · ISIN INE416D01022
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bliss GVS Pharma
Business
Business evidence pack
Source documentsPrimary material for understanding Bliss GVS Pharma
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
Bliss GVS Pharma Ltd - 506197 - Reg. 34 (1) Annual Report.BSE · annual report · 214 pages
VerifiedArchived copy Annual Report 2025 - Bliss GVS Pharma LimitedBSE · annual report · 239 pages
VerifiedArchived copy Updates - Bliss GVS Pharma LimitedNSE · annual report · 29 pages
VerifiedArchived copy Annual General Meeting - Bliss GVS Pharma LimitedNSE · annual report · 197 pages
VerifiedArchived copy Updates - Bliss GVS Pharma LimitedNSE · annual report · 173 pages
VerifiedArchived copy Financial Year 2019 from bseBSE · annual report · 177 pages
VerifiedArchived copy Financial Year 2012 from bseBSE · annual report · 81 pages
VerifiedArchived copy Financial Year 2015 from bseBSE · annual report · 117 pages
VerifiedArchived copy Financial Year 2024 from bseBSE · annual report · 131 pages
VerifiedArchived copy Financial Year 2025 from bseBSE · annual report · 239 pages
VerifiedArchived copy Financial Year 2016 from bseBSE · annual report · 135 pages
VerifiedArchived copy Financial Year 2020 from bseBSE · annual report · 177 pages
VerifiedArchived copy Financial Year 2023 from bseBSE · annual report · 112 pages
VerifiedArchived copy Financial Year 2014 from bseBSE · annual report · 96 pages
VerifiedArchived copy Financial Year 2017 from bseBSE · annual report · 133 pages
VerifiedArchived copy